Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

作者: Tiziano Barbui , Jürgen Thiele , Francesco Passamonti , Elisa Rumi , Emanuela Boveri

DOI: 10.1182/BLOOD-2011-11-393819

关键词:

摘要: We examined the prevalence and prognostic relevance of bone marrow reticulin fibrosis in 526 patients with World Health Organization–defined polycythemia vera evaluated at time initial diagnosis. Seventy-four (14%) displayed mostly grade 1 fibrosis, only 2 cases showing higher-grade fibrosis. Presenting clinical laboratory characteristics, including JAK2V617F allele burden, between without were similar for most part, exception a higher palpable splenomegaly ( P < .01). Patients less prone to experience thrombosis during their course (1.1 vs 2.7 per 100 patient-years; = .03) more develop post-polycythemia myelofibrosis (2.2 0.8 There was no significant difference groups terms overall or leukemia-free survival. The present study clarifies incidence, degree, obtained diagnosis vera.

参考文章(15)
T. Buhr, A. Georgii, H. Choritz, Myelofibrosis in Chronic Myeloproliferative Disorders: Incidence Among Subtypes According to the Hannover Classification Pathology Research and Practice. ,vol. 189, pp. 121- 132 ,(1993) , 10.1016/S0344-0338(11)80081-6
Ellis Jt, Peterson P, The bone marrow in polycythemia vera. Pathology. pp. 383- 403 ,(1979)
H. M. Kvasnicka, Jürgen Thiele, Diagnostic impact of bone marrow histopathology in polycythemia vera (PV) Histology and Histopathology. ,vol. 20, pp. 317- 328 ,(2005) , 10.14670/HH-20.317
Khadija Abdulkarim, Börje Ridell, Peter Johansson, Jack Kutti, Soodabeh Safai-Kutti, Björn Andréasson, The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera. European Journal of Haematology. ,vol. 86, pp. 148- 155 ,(2011) , 10.1111/J.1600-0609.2010.01548.X
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Juergen Thiele, Hans Michael Kvasnicka, Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis Current Hematologic Malignancy Reports. ,vol. 1, pp. 87- 92 ,(2006) , 10.1007/S11899-006-0028-1
Jerry L. Spivak, Polycythemia vera: myths, mechanisms, and management. Blood. ,vol. 100, pp. 4272- 4290 ,(2002) , 10.1182/BLOOD-2001-12-0349
A. Georgii, G. Buesche, A. Kreft, 2 The histopathology of chronic myeloproliferative diseases Baillière's clinical haematology. ,vol. 11, pp. 721- 749 ,(1998) , 10.1016/S0950-3536(98)80036-X
F Passamonti, E Rumi, D Pietra, C Elena, E Boveri, L Arcaini, E Roncoroni, C Astori, M Merli, S Boggi, C Pascutto, M Lazzarino, M Cazzola, A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia. ,vol. 24, pp. 1574- 1579 ,(2010) , 10.1038/LEU.2010.148